Efficacy and safety of first-line anlotinib-based combinations for advanced non-small cell lung cancer: a three-armed prospective study

Tianqing Chu,Wei Zhang,Bo Zhang,Runbo Zhong,Xueyan Zhang,Aiqin Gu,Chunlei Shi,Huimin Wang,Liwen Xiong,Jun Lu,Jianlin Qian,Yanwei Zhang,Yu Dong,Jiajun Teng,Zhiqiang Gao,Weimin Wang,Yinchen Shen,Wei Nie,Jeong Uk Lim,Hiren J. Mehta,Joel W. Neal,Yuqing Lou,Jianlin Xu,Hua Zhong,Baohui Han
DOI: https://doi.org/10.21037/tlcr-22-438
2022-07-29
Translational Lung Cancer Research
Abstract:Keywords: Non-small cell lung cancer (NSCLC); anlotinib; erlotinib; sintilimab; chemotherapy
oncology,respiratory system
What problem does this paper attempt to address?